Organic growth and currency benefits boost Clinigen profits
Profits at Burton-based pharma firm Clinigen have risen by 22% despite revenues falling for the year ending 30 June.
Profits for the year stood at £122.8m, while revenue dipped by 11% to £302.3m.
The firm is putting the hike in profits down to organic growth, a full-year's contribution from Link Healthcare and currency benefits.
Clinigen also hailed an "outstanding" year in its African and Asia Pacific markets.
Earlier this month, the firm announced the £150.3m acquisition of Quantum Pharma.
Shaun Chilton, group chi... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
